Annual Retained Earnings
-$253.15 M
-$30.15 M-13.52%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual retained earnings is -$253.15 million, with the most recent change of -$30.15 million (-13.52%) on December 31, 2023.
- During the last 3 years, NRXP annual retained earnings has fallen by -$162.97 million (-180.71%).
- NRXP annual retained earnings is now -180.71% below its all-time high of -$90.18 million, reached on December 31, 2020.
Performance
NRXP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$269.19 M
-$1.62 M-0.61%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly retained earnings is -$269.19 million, with the most recent change of -$1.62 million (-0.61%) on September 30, 2024.
- Over the past year, NRXP quarterly retained earnings has dropped by -$9.52 million (-3.67%).
- NRXP quarterly retained earnings is now -198.51% below its all-time high of -$90.18 million, reached on December 31, 2020.
Performance
NRXP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NRXP Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.5% | -3.7% |
| 3 y3 years | -180.7% | -26.5% |
| 5 y5 years | -180.7% | - |
NRXP Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.1% | at low | -46.9% | at low |
| 5 y | 5-year | -180.7% | at low | -198.5% | at low |
| alltime | all time | -180.7% | at low | -198.5% | at low |
NRx Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$269.19 M(+0.6%) |
| Jun 2024 | - | -$267.57 M(+3.0%) |
| Mar 2024 | - | -$259.68 M(+2.6%) |
| Dec 2023 | -$253.15 M(+13.5%) | -$253.15 M(+1.7%) |
| Sep 2023 | - | -$248.81 M(+2.5%) |
| Jun 2023 | - | -$242.75 M(+3.7%) |
| Mar 2023 | - | -$234.04 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$223.00 M(+21.7%) | -$223.00 M(+4.8%) |
| Sep 2022 | - | -$212.76 M(+4.5%) |
| Jun 2022 | - | -$203.67 M(+3.5%) |
| Mar 2022 | - | -$196.69 M(+7.3%) |
| Dec 2021 | -$183.24 M(+103.2%) | -$183.24 M(+20.2%) |
| Sep 2021 | - | -$152.45 M(+15.8%) |
| Jun 2021 | - | -$131.68 M(+46.0%) |
| Dec 2020 | -$90.18 M | -$90.18 M |
FAQ
- What is NRx Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual retained earnings year-on-year change?
- What is NRx Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly retained earnings year-on-year change?
What is NRx Pharmaceuticals annual retained earnings?
The current annual retained earnings of NRXP is -$253.15 M
What is the all time high annual retained earnings for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual retained earnings is -$90.18 M
What is NRx Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, NRXP annual retained earnings has changed by -$30.15 M (-13.52%)
What is NRx Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of NRXP is -$269.19 M
What is the all time high quarterly retained earnings for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly retained earnings is -$90.18 M
What is NRx Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, NRXP quarterly retained earnings has changed by -$9.52 M (-3.67%)